Viral mutations and host diversities that contribute to hepatocarcinogenesis
Viral mutations and host diversities that contribute to hepatocarcinogenesis
批准号:
14570449
负责人:
KATO Naoya
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The natural history of hepatitis virus infection consists of chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). However, the factors influencing disease progression to HCC have not been well elucidated. Here, we studied viral mutations and host diversities that contribute to hepatocarcinogenesis. 1) WBC DNAs were extracted from sera of 1.000 patients with hepatitis 13/C after obtaining written informed consent, and data base containing clinical data of these patients were constructed. Then, WBC DNA samples of 500 patients were anonymized by the method we established. 2) By analyzing hepatitis B virus (HBV) X gene nucleotide sequence in patients with/without HOC, it was revealed that amino acid substitution in codon 38 in HBx is significantly related with HOC. 3) Amino acid changes in C-terminal hydrophobic region of hepatitis C virus (HCV) core were observed more frequently in the interferon biological responders (BR) compared to interferon noivresponders (NR). Activatio … More n of Interleukin (IL)-8 promoter by core proteins significantly decreased after interferon therapy in the BR group compared to the NR group. Differences in amino acid sequence of HCV core possibly correlate with hepatitis activity by modulating IK-8 induction in HCV infected patients. 4) The effect of HCV core protein, HBx protein, and hepatitis delta virus large antigen on intracellular signaling pathway was determined. 5) Genetic polymorphsims of uidine 5'-diphosphate-glucuronosyltransferase 1A7 (UGT 1A7) and 1L-1β were investigated in 280 Japanese patients (122 with HCC) with chronic HCV infections. The proportions of UCT1A7 low activity allele (L)/L and high activity allel (H)/L in patients with HOC (25% and 45%, respectively) were higher than those in patients without HOC (15% and 39%, respectively) with an odds ratio of 2.7 and 1.8, respectively, comared with the UGT1A7 H/H. The IL-1β/-31 T/T genotype showed a significant association with the presence of HOC compared with the C/C genotype with an odds ratio of 2.9. 6) To search of single nucleotide polymorphisms(SNPs) for HOC susceptibility genes, 394 SNPs derived from 172 candidate genes were examined in 376 Japanese patients (including 170patients with HOC) with chronic HCV infection. Three SNPs derived from three genes were significantly associated with HOC. These SNPs and haplotypes will be used as markers to identify a subgroup at higher risk of HOC in Japanese patients with chronic HCV infection. Less
期刊论文(50)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kanda T, Kato N, et al.: "Hepatitis A virus VP3 may activate serum response element associated transcription."Scand J Gastroenterol. 38. 307-313 (2003)
Kanda T、Kato N 等人:“甲型肝炎病毒 VP3 可能激活血清反应元件相关转录。”Scand J Gastroenterol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wang Y et al.: "Interleukin-1β gene polymorphisms associated with nepatocellular carcinoma in hepattes C virus infection"Hepatology. 37. 65-71 (2003)
Wang Y等:“Interleukin-1β基因多态性与丙型肝炎病毒感染中的海细胞癌相关”Hepatology. 37. 65-71 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Goto T, Kato N, et al.: "Hepatitis B virus HBx and the large hepatitis Delta antigen synergistically activate the SRE-dependent pathway."J Infect Dis. 187. 820-828 (2003)
Goto T、Kato N 等人:“乙型肝炎病毒 HBx 和大肝炎 Delta 抗原协同激活 SRE 依赖性途径。”J Infect Dis。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hara K, Kato N, et al.: "Establishment of a method of anonymization of DNA samples in genetic research."J Hum Genet. 48. 327-330 (2003)
Hara K、Kato N 等人:“遗传研究中 DNA 样本匿名化方法的建立。”J Hum Genet。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wang Y, Kato N, Hoshida Y, Otsuka M, Taniguchi H, Moriyama M, Shiina S, Kawabe T, Ito YM, Omata M.: "UDP-glucournosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in Japanese patients with hepatitis C virus infection."
Wang Y、Kato N、Hoshida Y、Otsuka M、Taniguchi H、Moriyama M、Shiina S、Kawabe T、Ito YM、Omata M.:“UDP-葡萄糖醛酸转移酶 1A7 遗传多态性与日本丙型肝炎病毒患者的肝细胞癌相关
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Interferon stimulated genes and its polymorphisms determining Hepatitis C virus replication and pathogenesis of hepatitis C
-
批准号:20590760
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:KATO Naoya
-
依托单位:
Comprehensive analysis of hepatitis Cvirus protein that disturb host interferon system
-
批准号:18590718
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:KATO Naoya
-
依托单位:
Analyses of the individual risk for hepatocellular carcinoma by large scale search of single nucleotide polymorphisms of cytokine genes
-
批准号:16590578
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2004
-
负责人:KATO Naoya
-
依托单位:
Molecular mechanism of inflammatory cytokine induction by hepatitis viruses
-
批准号:12670462
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2000
-
负责人:KATO Naoya
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RBM38基因SNP对人红细胞卟啉代谢的影响
-
批准号:2025JJ81130
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘康
-
依托单位:
风险SNP介导的增强子通过FAM13A在哮喘
肺泡巨噬细胞中引发M1型炎症的机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:程一森
-
依托单位:
FST基因调控猪乳腺原基上皮细胞功能研究及其因果SNP位点鉴定
-
批准号:2025JJ60129
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘晨曦
-
依托单位:
图表示学习的SNP模型研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郭平
-
依托单位:
草鱼 C3 基因 SNP 位点的筛选及其与 GCRV 抗性的
关联分析
-
批准号:2024JJ5199
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:熊舒婷
-
依托单位:
基于 SNP 标记的罗氏沼虾种质资源鉴定平台
的构建
-
批准号:TGN24C190014
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:易少奎
-
依托单位:
依赖转录因子CTCF的功能性SNP在双相情感障碍发病中的机制研究
-
批准号:82301711
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:顾孝静
-
依托单位:
染色质环挤压介导肥胖易感SNP上位效应激活条件性增强子调控NOTCH4基因表达的机制研究
-
批准号:32370653
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:郭燕
-
依托单位:
SNP rs970547通过降低COL12A1蛋白稳定性启动内质网应激诱发前交叉韧带损伤易感的机制研究
-
批准号:82360418
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:陈鸿
-
依托单位:
新易感SNP通过GATA3调控RORγt+FOXP3+Treg细胞稳定性致1型糖尿病的机制研究
-
批准号:82370828
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:张梅
-
依托单位: